Details of the Drug

General Information of Drug (ID: DM3BF9B)

Drug Name
DFN-15
Indication
Disease Entry ICD 11 Status REF
Migraine 8A80 Phase 3 [1]
Cross-matching ID
PubChem CID
2662
TTD ID
D03BIH
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug Pharmacogenomic Perturbation (DPP)NEW Click to Jump to the Detailed DPP Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Combinatorial Drugs (CBD) Click to Jump to the Detailed CBD Information of This Drug

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)